newsfilter
← Latest News
GlobeNewswire·

Creative Medical Technology Reports Positive One-Year Results for AlloStem™ Type 2 Diabetes Program

PHOENIX, Feb. 11, 2025 (GLOBE NEWSWIRE) -- Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ), a clinical-stage biotechnology company advancing regenerative medicine solutions, today announced promising one-year